NCT05361161View on ClinicalTrials.gov

Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC)

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2025

Conditions

Gastric CancerEmbolization

Interventions

DRUG

Transarterial Chemoembolization

Arterial infusion chemotherapy (THP + oxaliplatin + raltitrexed) and THP combined with lipiodol embolization for 2 times, with an interval of 1 month.

All Listed Sponsors

lead

Gang Wu

OTHER

NCT05361161 - Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC) | Biotech Hunter | Biotech Hunter